Disclosure of Adverse Events and Medical Errors: A Framework for Anesthesiologists.


Journal

Anesthesiology clinics
ISSN: 1932-2275
Titre abrégé: Anesthesiol Clin
Pays: United States
ID NLM: 101273663

Informations de publication

Date de publication:
Sep 2024
Historique:
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 25 7 2024
Statut: ppublish

Résumé

Ethical disclosure of adverse events (AE) presents opportunities and challenges for physicians and has unique ramifications for anesthesiologists. AE disclosure is supported by patients, regulatory organizations, and physicians. Disclosure is part of a physician's ethical duty toward patients, supports fully informed patient decision making, and is a critical component of root cause analysis. Barriers to AE disclosure include disruption of the doctor-patient relationship, fear of litigation, and inadequate training. Apology laws intended to support disclosure and mitigate concern for adverse legal consequences have not fulfilled that initial promise. Training and institutional communication programs support physicians in providing competent, ethical AE disclosure.

Identifiants

pubmed: 39054025
pii: S1932-2275(23)00121-0
doi: 10.1016/j.anclin.2023.12.003
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-538

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure K.O. Heller and K.J. Souter have no relevant commercial or financial conflicts of interest and no funding sources to disclose.

Auteurs

Katherine O Heller (KO)

Department of Anesthesiology and Pain Medicine, University of Washington Medical Center, Seattle, WA, USA. Electronic address: oldenk@uw.edu.

Karen J Souter (KJ)

Department of Anesthesiology and Pain Medicine, University of Washington Medical Center, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH